Alzheimer's & Dementia: The Journal of the Alzheimer's Association
Volume 3, Issue 4 , Pages 333-335 , October 2007

Structural neuroimaging in the diagnosis of dementia

  • Tiffany Chow

      Affiliations

    • Corresponding Author InformationCorresponding author. Tel.: (416) 785-2500 x3459; Fax: (416) 785-2862.

References 

  1. Chui H, Zhang Q. Evaluation of dementia: a systematic study of the usefulness of the American Academy of Neurology’s practice parameters. Neurology. 1997;49:925–935
  2. Freter SBH, Gold S, Chertkow H, Clarfield AM. Prevalence of potentially reversible dementias and actual reversibility in a memory clinic cohort. CMAJ. 1998;159:657–662
  3. Gifford DR, Holloway RG, Vickrey BG. Systematic review of clinical prediction rules for neuroimaging in the evaluation of dementia. Arch Intern Med. 2000;160:2855–2862
  4. Martin DC, Miller J, Kapoor W, Karpf M, Boller F. Clinical prediction rules for computed tomographic scanning in senile dementia. Arch Intern Med. 1987;147:77–80
  5. Alexander EM, Buchner DM, Cain KC, Larson EB. Do surgical brain lesions present as isolated dementia? (a population-based study). J Am Geriatr Soc. 1995;43:138–143
  6. Foster GR, Scott DA, Payne S. The use of CT scanning in dementia: a systematic review. Int J Technol Assess Health Care. 1999;15:406–423
  7. Walstra GJM, Teunisse S, van Gool HvC. Reversible dementia in elderly patients referred to a memory clinic. J Neurol. 1997;244:17–22
  8. Clarfield AM. The decreasing prevalence of reversible dementias: an updated meta-analysis. Arch Intern Med. 2003;163:2219–2229
  9. Chong MS, Sahadevan S. An evidence-based clinical approach to the diagnosis of dementia. Ann Acad Med Singapore. 2003;32:740–748
  10. Simon D. Routine imaging in suspected dementia: diagnostic and therapeutic yield. Clin Res. 1992;40:565A
  11. Jobst KA, Barnetson LP, Shepstone BJ. Accurate prediction of histologically confirmed Alzheimer’s disease and the differential diagnosis of dementia: the use of NINCDS-ADRDA and DSM-III-R criteria, SPECT, X-ray CT, and APO E4 medial temporal lobe dementias—the Oxford Project to Investigate Memory and Aging. Int Psychogeriatr. 1997;(Suppl 1):191–222discussion 247–52
  12. Zakzanis KK. Quantitative evidence for neuroanatomic and neuropsychological markers in dementia of the Alzheimer’s type. J Clin Exp Neuropsychol. 1998;20:259–269
  13. Frisoni GB, Weiss C, Geroldi C, Bianchetti A, Trabucchi M. Linear measures of atrophy in mild Alzheimer disease. AJNR Am J Neuroradiol. 1996;17:913–923
  14. Laakso MP, Soininen H, Partanen K, Lehtovirta M, Hallikanen M, Hanninen T. HMHTHEVPRP. MRI of the hippocampus in Alzheimer’s disease: sensitivity, specificity, and analysis of the incorrectly classified subjects. Neurobiol Aging. 1998;19:23–31
  15. Massoud F, Devi G, Moroney JT, Stern Y, Lawton A, Bell K, et al. The role of routine laboratory studies and neuroimaging in the diagnosis of dementia: a clinicopathological study. J Am Geriatr Soc. 2000;48:1204–1210
  16. Wilcock G, Mobius HJ, Stoffler A MMM 500 group. A double-blind, placebo-controlled multicentre study of memantine in mild to moderate vascular dementia (MMM500). Int Clin Psychopharmacol. 2002;17:297–305
  17. Lopez OL, Kuller LH, Becker JT, Jagust WJ, DeKosky ST, Fitzpatrick A, et al. Classification of vascular dementia in the Cardiovascular Health Study Cognition Study. Neurology. 2005;64:1539–1547
  18. Killiany RJ, Gomez-Isla T, Moss MB, Kikinis R, Jolesz F, Tanzi R, et al. MRI measures of entorhinal cortex vs hippocampus in preclinical AD. Neurology. 2002;58:1188–1196
  19. Rusinek H, Frid D, Tsui WH, Tarshish CY, Convit A, de Leon MJ. Regional brain atrophy rate predicts future cognitive decline: 6-year longitudinal MR imaging study of normal aging. Radiology. 2003;229:691–696
  20. Jack CR, Shiung MM, Weigand SD, O’Brien PC, Gunter JL, Boeve BF, et al. Brain atrophy rates predict subsequent clinical conversion in normal elderly and amnestic MCI. Neurology. 2005;65:1227–1231
  21. Frisoni GB, Scheltens P, Galluzzi S, Nobili FM, Fox NC, Robert PH, et al. Neuroimaging tools to rate regional atrophy, subcortical cerebrovascular disease, and regional cerebral blood flow and metabolism: consensus paper of the EADC. J Neurol Neurosurg Psychiatry. 2003;74:1371–1381
  22. Cardenas VA, Hardin D, Ezekiel F, Weber P, Jagust WJ, Chui HC, et al. Comparison of methods for measuring longitudinal brain change in cognitive impairment and dementia. Neurobiol Aging. 2003;24:537–544
  23. Zamrini E, De Santi S, Tolar M. Imaging is superior to cognitive testing for early diagnosis of Alzheimer’s disease. Neurobiol Aging. 2004;25:685–691
  24. Organizing Committee CCCotAoD. Assessing dementia: the Canadian Consensus. CMAJ. 1991;144:851–853

PII: S1552-5260(07)00559-6

doi: 10.1016/j.jalz.2007.07.016

Alzheimer's & Dementia: The Journal of the Alzheimer's Association
Volume 3, Issue 4 , Pages 333-335 , October 2007

Article Tools